Neprilysin as Heart Failure biomarker (sNEP)

Developed by: Fundació Institut d´Investigació en Ciències de la Salut Germans Trias i Pujol

Description

Cardiac biomarkers allow physicians an opportunity to combine clinical observations with objectively measured sub-clinical information in making treatment decisions.

Desired cooperation

EXCLUSIVE WORLDWIDE LICENSE AGREEMENT
Status:
Comercializado
Health technology:
Biotecnología y Diagnóstico Molecular (proteómica, genómica, etc...), Medicamentos - Farma